Literature DB >> 15507928

Managing the sexually transmitted disease pandemic: a time for reevaluation.

Stephen J Genuis1, Shelagh K Genuis.   

Abstract

The serious implications of the sexually transmitted disease (STD) pandemic that currently challenges educators, medical practitioners and governments suggest that prevention strategies, which primarily focus on barrier protection and the management of infection, must be reevaluated and that initiatives focusing on primary prevention of behaviors predisposing individuals to STD risk must be adopted. Human immunodeficiency virus/acquired immunodeficiency syndrome, human papillomavirus, genital herpes, and Chlamydia are used to illustrate the pervasive presence of STDs and their serious consequences for individuals and national infrastructures. Long-term sequelae are discussed, including the emerging link between various sexually transmitted infections and cancer, and the psychosexual and psychosocial factors which impact infected individuals. Although risk reduction and treatment of existing infection is critical, the promotion of optimal life-long health can be achieved most effectively through delayed sexual debut, partner reduction, and the avoidance of risky sexual behaviors.

Entities:  

Mesh:

Year:  2004        PMID: 15507928     DOI: 10.1016/j.ajog.2004.03.019

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Are condoms the answer to rising rates of non-HIV sexually transmitted infection? No.

Authors:  Stephen J Genuis
Journal:  BMJ       Date:  2008-01-26

2.  Influence of Contraception Use on the Reproductive Health of Adolescents and Young Adults.

Authors:  Richard J Fehring; Thomas Bouchard; Maria Meyers
Journal:  Linacre Q       Date:  2018-04-25

3.  Prevalence of HIV, Hepatitis B, syphilis, and chlamydia among adults seeking treatment for a mental disorder in southern India.

Authors:  Michael P Carey; V Ravi; Prabha S Chandra; Anita Desai; Dan J Neal
Journal:  AIDS Behav       Date:  2007-03

4.  Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women from a rural area of southern Mozambique.

Authors:  Clara Menéndez; Xavier Castellsagué; Montse Renom; Jahit Sacarlal; Llorenç Quintó; Belen Lloveras; Joellen Klaustermeier; Janet R Kornegay; Betuel Sigauque; F Xavier Bosch; Pedro L Alonso
Journal:  Infect Dis Obstet Gynecol       Date:  2010-07-11

5.  Comparison of Genital Chlamydia trachomatis Infection Incidence Between Women With Infertility and Healthy Women in Iran Using PCR and Immunofluorescence Methods.

Authors:  Seyed Mahmoud Amin Marashi; Zahra Moulana; Abbas Ali Imani Fooladi; Mohammad Mashhadi Karim
Journal:  Jundishapur J Microbiol       Date:  2014-04-01       Impact factor: 0.747

6.  Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland.

Authors:  Themba G Ginindza; Cristina D Stefan; Joyce M Tsoka-Gwegweni; Xolisile Dlamini; Pauline E Jolly; Elisabete Weiderpass; Nathalie Broutet; Benn Sartorius
Journal:  Infect Agent Cancer       Date:  2017-05-25       Impact factor: 2.965

Review 7.  Training room management of medical conditions: infectious diseases.

Authors:  Robert G Hosey; Richard E Rodenberg
Journal:  Clin Sports Med       Date:  2005-07       Impact factor: 2.182

8.  Chlamydia screening practices among physicians and community nurses in Yukon, Canada.

Authors:  Karolina Machalek; Brendan E Hanley; Joy N Kajiwara; Paula E Pasquali; Cathy J Stannard
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

9.  The prevalence and associated factors of Treponema pallidum among HIV-positive and HIV-negative individuals who attended voluntary counseling and testing center of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia: A cross-sectional study design.

Authors:  Habtamu Weldesenbet; Daniel Asrat; Yimtubezinash Weldeamanuel
Journal:  SAGE Open Med       Date:  2020-02-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.